at Chapel Hill School of Public Health, and Senior Scholar, Department of Health Policy, Jefferson Medical College.
Joshua T. Cohen, Ph.D., is a Lecturer at the Tufts New England Medical Center Institute for Clinical Research and Health Policy Studies, in the Center for the Evaluation of Value and Risk. Dr. Cohen’s research focuses on the application of decision analytic techniques to public health risk management problems with a special emphasis on the proper characterization and analysis of uncertainty. His work covers a range of issues, including cell phone use while driving, alternative fuels for transit buses and school buses, tradeoffs between the nutritional benefits of fish and resulting exposure to mercury, and the risks associated with bovine spongiform encephalopathy in the United States. Dr. Cohen currently serves on a National Academy of Sciences committee charged with reviewing the U.S. Environmental Protection Agency (EPA)’s risk assessment of dioxin, and on the EPA’s Clean Air Science Advisory Committee that is now reviewing the Agency’s latest air quality criteria document for lead. He received both his Ph.D. in Decision Sciences and his B.A. in Applied Mathematics from Harvard University.
A. Mark Fendrick, M.D., is a Professor of Internal Medicine in the School of Medicine and a Professor of Health Management and Policy in the School of Public Health at the University of Michigan. Dr. Fendrick received a bachelor’s degree in economics and chemistry from University of Pennsylvania and his medical degree from Harvard. Dr. Fendrick completed his residency in internal medicine at the University of Pennsylvania where he was a fellow in the Robert Wood Johnson Foundation Clinical Scholars Program. He currently directs the Health Services Research Core Laboratory and is co-director of the recently established Center for Value-Based Insurance Design at the University of Michigan. Dr. Fendrick’s research focuses on the clinical and economic assessment of medical interventions with special attention to how technological innovation influences clinical practice and impacts health care systems. He has authored over 200 articles and book chapters and lectures frequently on the health and cost implications of medical interventions to diverse audiences around the world. Dr. Fendrick remains clinically active in the practice of general internal medicine. He is the co-editor in chief of the American Journal of Managed Care and is an editorial board member for 3 additional peer-reviewed publications. His perspective and understanding of clinical and economic issues have fostered collaborations with numerous government agencies, health plans, professional societies, and health care companies. He serves on the Medicare Coverage Advisory Committee.